Hosted on MSN10mon
Groundbreaking immunotherapy shrinks aggressive brain tumor in new trial
in three patients with EGFR-expressing glioblastoma. The 72-year-old male patient had undergone standard therapies, only to have his tumor return. MRI scans taken just a day after receiving the ...
Hosted on MSN11mon
Early clinical trial results show 'dramatic and rapid' regression of glioblastoma after next generation CAR-T therapy
her team engineered these CAR-T cells to deliver TEAMs against wild-type EGFR, which is not detected in normal brain tissue but is expressed in more than 80% of cases of GBM. The combination ...
Medscape8d
Treatment Options for Recurrent Glioblastoma: Pitfalls and Future Trends
Recent advances in the understanding of molecular and cytogenetic pathways that influence tumor growth, invasion, angiogenesis and apoptosis have led to the direct targeting of the aberrant ...
First patient in Rhode Island receives novel gamma tile treatment for glioblastoma
That was on Nov. 25. This time, Chen, as part of a clinical trial at Rhode Island Hospital used a radiation treatment, on the ...
pharmaphorum5y
AbbVie pulls phase 3 ADC trials in glioblastoma after survival miss
and the programme joins an increasing body of drugs that have failed to move the needle in glioblastoma. That includes several small-molecule and antibody-based EGFR inhibitors, including ImClone ...